L Bocket
Overview
Explore the profile of L Bocket including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alidjinou E, Robineau O, Huleux T, Meybeck A, Hober D, Ajana F, et al.
Infect Dis Now
. 2022 Mar;
52(5):315-317.
PMID: 35283341
No abstract available.
2.
Alidjinou E, Bocket L, Pigot V, Lambert V, Hallaert C, Canva V, et al.
Diagn Microbiol Infect Dis
. 2018 Jan;
90(4):277-279.
PMID: 29310947
We compared the Sanger sequencing and the commercial INNO-LiPA® HBV assay for the routine detection of precore (PC) and basal core promoter (BCP) mutations of hepatitis B virus in chronically...
3.
Alidjinou E, Deldalle J, Hallaert C, Robineau O, Ajana F, Choisy P, et al.
J Antimicrob Chemother
. 2017 Nov;
72(10):2823-2830.
PMID: 29091197
Background: Sanger sequencing of plasma RNA is the standard method for HIV-1 drug resistance testing in treatment-naive patients, but is limited by the non-detection of resistance-associated mutations (RAMs) with prevalence...
4.
Melliez H, Duhamel A, Robineau O, Bocket L, Kim I, Sauser E, et al.
Eur J Clin Microbiol Infect Dis
. 2017 Jun;
36(11):2085-2092.
PMID: 28647858
Determinants of persistent low-level viraemia [PLLV, a viral load (VL) of between 50 and 500 copies/mL] have not been elucidated. In a case-control study, we evaluated the influence of micronutrients...
5.
Alidjinou E, Robineau O, Cheret A, Ajana F, Drumez E, Kyheng M, et al.
J Infect
. 2016 Dec;
74(4):420-422.
PMID: 27998749
No abstract available.
6.
Bocket L, Peytavin G, Alidjinou E, Ajana F, Choisy P, Le M, et al.
J Antimicrob Chemother
. 2016 May;
71(9):2651-3.
PMID: 27234463
Objectives: There are few data on clinical and virological factors associated with maraviroc virological response (VR) in clinical practice. This study aimed to identify factors associated with VR in 94...
7.
Alidjinou E, Lazrek M, Libier L, Bocket L, Dewilde A, Engelmann I, et al.
J Clin Virol
. 2015 Dec;
75:60-3.
PMID: 26679224
We here report the case of a 30-year old man with a history of ulcerative colitis, who presented clinical and biological features compatible with a viral hepatitis. Initial serological results...
8.
Alidjinou E, Bocket L, Hober D
Pathol Biol (Paris)
. 2014 Sep;
63(1):53-9.
PMID: 25201144
Effective antiretroviral therapy usually leads to undetectable HIV-1 RNA in the plasma. However, the virus persists in some cells of infected patients as various DNA forms, both integrated and unintegrated....
9.
Bocket L, Chevaliez S, Talbodec N, Sobaszek A, Pawlotsky J, Yazdanpanah Y
Clin Microbiol Infect
. 2010 Apr;
17(2):238-41.
PMID: 20412189
Tracing risk factors for acquiring hepatitis C virus (HCV) in an HCV-infected patient, the only identified risk was working at the same butcher's counter of a supermarket as another HCV-infected...
10.
Deltenre P, Canva V, El Nady M, Francois C, Castelain S, Dharancy S, et al.
J Viral Hepat
. 2009 May;
16(7):500-5.
PMID: 19457138
The most reliable predictor of a sustained virological response in patients with persistently normal ALT has not been identified. We analysed 17 patients with genotype 1 chronic HCV who underwent...